查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947770

工程蚊虫防治市场分析及预测（至2035年）：依类型、产品、服务、技术、应用、最终使用者、流程、部署及解决方案划分

Engineered Mosquito Control Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Process, Deployment, Solutions
出版日期: | 出版商: Global Insight Services | 英文 384 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到2034年，基因工程蚊虫控制市场规模将从2024年的5.616亿美元成长至7.621亿美元，年复合成长率约为3.1%。该市场涵盖旨在减少蚊虫数量和蚊媒疾病的创新生物技术解决方案，包括基因改造蚊子、不孕昆虫技术和微生物控制方法。随着疟疾和登革热等媒介传播疾病日益成为全球健康挑战，对永续且有针对性的蚊虫控制解决方案的需求也日益增长。基因工程技术的进步、监管支持以及公共卫生资金的增加正在推动市场发展，凸显了这一关键领域的成长机会。

由于对有效病媒控制方案的迫切需求，工程蚊虫控制市场正经历强劲成长。生物防治领域处于主导，基因改造蚊子在减少蚊媒疾病方面展现出良好的效果。不孕昆虫技术（SIT）是该领域的重要细分市场，因其环保特性而日益受到关注。化学防治也紧随其后，针对蚊子幼虫和成虫的创新杀虫剂不断涌现。生物农药已成为关键的细分市场，反映出人们对永续害虫防治方案的日益青睐。

市场区隔
类型 遗传控制、生物控制、机械控制、化学控制
产品 基因改造蚊子、生物杀虫剂、蚊子诱捕器、杀幼虫剂、杀成虫剂、昆虫生长调节剂、驱蚊剂
服务 现场测试、监测、咨询、法规遵循
科技 CRISPR基因编辑技术、不孕昆虫技术、 RNA干扰技术、沃尔巴克氏体方法
应用领域 公共卫生、农业、住宅和商业
最终用户 政府机构、非政府组织、研究机构、农业部门和卫生设施
流程 昆虫释放、田间监测和数据分析
如何安装 本地、远端
解决方案 综合虫害管理，单一解决方案

数位技术在蚊虫控制策略中的应用也活性化了市场动态。遥感探测和数据分析工具正在优化蚊虫监测和控制活动。公共卫生措施推动了对综合蚊虫控制方案的需求。对研发的加速投入促进了生技公司与公共卫生机构之间的合作。这些趋势为市场持续扩张和创新提供了可能。

基因改造蚊虫控制市场正经历市场份额、定价策略和产品创新方面的动态变化。各公司日益注重开发兼顾都市区和农村地区的高性价比解决方案。新产品的推出强调环保和永续理念，反映了人们日益增强的环保意识。此市场产品种类繁多，均旨在为蚊媒疾病提供有效的解决方案。随着消费者意识的提高，定价策略竞争日益激烈，各公司都在努力平衡价格优势与先进技术。

工程蚊虫控制市场竞争异常激烈，主要企业不断进行标竿对比，以维持竞争优势。监管影响至关重要，北美和欧洲等地区对产品核可和使用制定了严格的标准。这些法规既可能抑制创新，也可能促进创新，这取决于企业如何适应。此外，生技公司与政府机构之间的合作也不断加强，旨在提高产品的功效和覆盖范围。随着市场的发展，了解这些竞争动态和法律规范对于策略定位和成长至关重要。

主要趋势和驱动因素：

由于人们对蚊媒疾病的日益关注，基因工程蚊虫控制市场正经历强劲成长。一个关键趋势是采用基因工程技术培育能够抑制蚊虫数量和疾病传播的蚊株。各国政府和卫生组织正投资研发创新的蚊虫防治方法，以对抗疟疾和登革热等疾病。

技术进步使得蚊虫控制方案更加精准有效。 CRISPR技术的开发促进了基因改造蚊子的培育，这些蚊子经过基因改造，可用于控制蚊虫数量或预防疾病传播。公众接受度和监管部门的核准是影响市场趋势的关键因素。

此外，公共卫生机构与生技公司之间的合作正在促进创新。这些伙伴关係旨在开发永续且扩充性的解决方案。随着全球对有效蚊虫控制方案的认识和需求不断增长，预计市场将显着增长。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 基因调控
    • 生物防治
    • 机械控制
    • 化学防治
  • 市场规模及预测：依产品划分
    • 基因改造蚊子
    • 生物农药
    • 蚊子诱捕器
    • 杀幼虫剂
    • 杀成虫剂
    • 昆虫生长调节剂
    • 驱虫剂
  • 市场规模及预测：依服务划分
    • 实地测试
    • 监测/监控
    • 咨询
    • 监理合规
  • 市场规模及预测：依技术划分
    • CRISPR基因编辑
    • 不孕昆虫技术
    • RNA干扰
    • 沃尔巴克氏体法案
  • 市场规模及预测：依应用领域划分
    • 公共卫生
    • 农业
    • 住宅
    • 商业
  • 市场规模及预测：依最终用户划分
    • 政府机构
    • 非政府组织（NGO）
    • 研究所
    • 农业
    • 医疗设施
  • 市场规模及预测：依製程划分
    • 昆虫释放
    • 现场监测
    • 数据分析
  • 市场规模及预测：依发展状况
    • 当地的
    • 偏僻的
  • 市场规模及预测：按解决方案划分
    • 综合虫害管理
    • 独立解决方案

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Oxitec
  • Intrexon
  • Mosquito Mate
  • Verily Life Sciences
  • Bio Mosquito
  • Skeeter Control
  • Vestergaard
  • Arctech Innovation
  • In2 Care
  • Ginkgo Bioworks
  • M2 M Biotechnologies
  • Bayer Crop Science Biologics
  • Geneworks
  • Aqua Bounty Technologies
  • Eden Research
  • Provivi
  • Senes Tech
  • Adapco
  • Clarke Mosquito Control
  • Valent Bio Sciences

第九章：关于我们

简介目录
Product Code: GIS10955

Engineered Mosquito Control Market is anticipated to expand from $561.6 million in 2024 to $762.1 million by 2034, growing at a CAGR of approximately 3.1%. The Engineered Mosquito Control Market encompasses innovative biotechnological solutions aimed at reducing mosquito populations and the diseases they transmit. This market includes genetically modified mosquitoes, sterile insect techniques, and microbial control methods. As vector-borne diseases like malaria and dengue pose significant global health challenges, demand for sustainable, targeted mosquito control solutions is rising. The market is driven by advancements in genetic engineering, regulatory support, and increased public health funding, highlighting opportunities for growth and development in this critical sector.

The Engineered Mosquito Control Market is experiencing robust growth, driven by the urgent need for effective vector control solutions. The biological control segment is leading, with genetically modified mosquitoes offering promising results in reducing mosquito-borne diseases. Sterile insect technique (SIT) is a key sub-segment, gaining traction due to its environmentally friendly approach. Chemical control follows closely, with the development of innovative insecticides that target mosquito larvae and adults. Biopesticides are emerging as a significant sub-segment, reflecting an increasing preference for sustainable pest management solutions.

Market Segmentation
TypeGenetic Control, Biological Control, Mechanical Control, Chemical Control
ProductGenetically Modified Mosquitoes, Biopesticides, Mosquito Traps, Larvicides, Adulticides, Insect Growth Regulators, Repellents
ServicesField Trials, Monitoring & Surveillance, Consulting, Regulatory Compliance
TechnologyCRISPR Gene Editing, Sterile Insect Technique, RNA Interference, Wolbachia Method
ApplicationPublic Health, Agriculture, Residential, Commercial
End UserGovernment Agencies, Non-Governmental Organizations, Research Institutions, Agricultural Sector, Healthcare Facilities
ProcessRelease of Insects, Field Monitoring, Data Analysis
DeploymentOn-Site, Remote
SolutionsIntegrated Pest Management, Standalone Solutions

The integration of digital technology in mosquito control strategies is also enhancing market dynamics. Remote sensing and data analytics tools are optimizing mosquito surveillance and intervention efforts. Public health initiatives are boosting demand for integrated mosquito management programs. The focus on research and development is accelerating, fostering collaborations between biotech firms and public health organizations. These trends underscore the market's potential for continued expansion and innovation.

The Engineered Mosquito Control Market is witnessing a dynamic shift in market share, pricing strategies, and product innovations. Companies are increasingly focusing on developing cost-effective solutions that cater to both urban and rural areas. New product launches are emphasizing eco-friendly and sustainable approaches, reflecting a broader trend towards environmental consciousness. The market is characterized by a diverse range of offerings, each aiming to provide effective solutions to mosquito-borne diseases. As consumer awareness grows, pricing strategies are becoming more competitive, with companies striving to balance affordability and advanced technology.

Competition in the Engineered Mosquito Control Market is intensifying, with key players continuously benchmarking against each other to maintain a competitive edge. Regulatory influences play a significant role, as policies in regions like North America and Europe set stringent standards for product approval and usage. These regulations can both hinder and drive innovation, depending on the adaptability of companies. The market is also witnessing collaborations between biotech firms and governmental bodies, aiming to enhance product efficacy and reach. As the market evolves, understanding these competitive dynamics and regulatory frameworks is crucial for strategic positioning and growth.

Tariff Impact:

Global tariffs and geopolitical tensions are critically influencing the Engineered Mosquito Control Market, particularly in East Asia. Japan and South Korea, traditionally reliant on imports, are now investing in local biotech innovations to mitigate tariff impacts. China is accelerating its domestic mosquito control technologies, driven by export restrictions and a strategic pivot towards self-reliance. Taiwan, while a key player in biotech manufacturing, navigates geopolitical uncertainties with cautious alliances. The parent market is witnessing robust growth, propelled by rising demand for vector control solutions amid climate change. By 2035, the market is projected to thrive, contingent on regional collaborations and technological advancements. Middle East conflicts, though less directly impactful, could disrupt global supply chains and energy prices, indirectly influencing production costs and market dynamics.

Geographical Overview:

The engineered mosquito control market is witnessing dynamic growth across various regions, each presenting unique opportunities. North America leads the sector, driven by advanced biotechnology research and proactive vector control initiatives. The region's focus on public health safety and innovation paves the way for significant market expansion. Europe follows closely, with stringent regulatory frameworks supporting sustainable mosquito control solutions.

The region's commitment to environmental sustainability and public health protection enhances its market potential. In Asia Pacific, the market is rapidly expanding, propelled by increasing urbanization and rising awareness about mosquito-borne diseases. Countries like India and China are emerging as key players, investing in innovative mosquito control technologies. Latin America and the Middle East & Africa present promising growth pockets. In Latin America, heightened government efforts to curb mosquito-borne illnesses drive market demand, while the Middle East & Africa recognize the need for effective mosquito control solutions to safeguard public health and support economic development.

Key Trends and Drivers:

The engineered mosquito control market is experiencing robust growth driven by increasing concerns about mosquito-borne diseases. Key trends include the adoption of genetic engineering techniques to develop mosquito strains that can reduce populations or transmission of diseases. Governments and health organizations are investing in innovative mosquito control methods to combat diseases like malaria and dengue.

Technological advancements are enabling more precise and effective mosquito control solutions. The development of CRISPR technology has facilitated the creation of genetically modified mosquitoes. These mosquitoes are designed to either suppress populations or prevent disease transmission. Public acceptance and regulatory approvals are crucial drivers that influence the market's trajectory.

Furthermore, collaborations between public health bodies and biotech companies are fostering innovation. These partnerships aim to develop sustainable and scalable solutions. The market is poised for significant growth as awareness and demand for effective mosquito control solutions continue to rise globally.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Genetic Control
    • 4.1.2 Biological Control
    • 4.1.3 Mechanical Control
    • 4.1.4 Chemical Control
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Genetically Modified Mosquitoes
    • 4.2.2 Biopesticides
    • 4.2.3 Mosquito Traps
    • 4.2.4 Larvicides
    • 4.2.5 Adulticides
    • 4.2.6 Insect Growth Regulators
    • 4.2.7 Repellents
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Field Trials
    • 4.3.2 Monitoring & Surveillance
    • 4.3.3 Consulting
    • 4.3.4 Regulatory Compliance
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 CRISPR Gene Editing
    • 4.4.2 Sterile Insect Technique
    • 4.4.3 RNA Interference
    • 4.4.4 Wolbachia Method
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Public Health
    • 4.5.2 Agriculture
    • 4.5.3 Residential
    • 4.5.4 Commercial
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Government Agencies
    • 4.6.2 Non-Governmental Organizations
    • 4.6.3 Research Institutions
    • 4.6.4 Agricultural Sector
    • 4.6.5 Healthcare Facilities
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Release of Insects
    • 4.7.2 Field Monitoring
    • 4.7.3 Data Analysis
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 On-Site
    • 4.8.2 Remote
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Integrated Pest Management
    • 4.9.2 Standalone Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Deployment
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Deployment
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Deployment
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Deployment
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Deployment
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Deployment
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Deployment
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Deployment
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Deployment
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Deployment
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Deployment
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Deployment
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Deployment
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Deployment
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Deployment
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Deployment
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Deployment
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Deployment
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Deployment
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Deployment
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Deployment
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Deployment
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Deployment
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Deployment
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Oxitec
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Intrexon
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Mosquito Mate
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Verily Life Sciences
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Bio Mosquito
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Skeeter Control
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Vestergaard
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Arctech Innovation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 In2 Care
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Ginkgo Bioworks
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 M2 M Biotechnologies
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Bayer Crop Science Biologics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Geneworks
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Aqua Bounty Technologies
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Eden Research
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Provivi
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Senes Tech
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Adapco
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Clarke Mosquito Control
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Valent Bio Sciences
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us